Evaluation of CPAF Mediated Anti-Chlamydial Immunity in the Guinea Pig

CPAF 介导的豚鼠抗衣原体免疫的评价

基本信息

项目摘要

DESCRIPTION (provided by applicant): Chlamydia trachomatis is the leading cause of bacterial sexually transmitted disease worldwide. Untreated genital chlamydial infections cause serious sequelae such as pelvic inflammatory disease, ectopic pregnancy, and infertility. A licensed vaccine, which is considered to be the ideal way to limit Chlamydia-induced morbidity, is currently not available. Chlamydial protease- like activity factor (CPAF) is a highly conserved bacterial protein secreted into the host cytosol. Our laboratory has shown the protective efficacy of intranasal vaccination with recombinant(r) CPAF (serovar L2) against genital chlamydial infection and pathology in mice. This protection is mediated by antigen-specific CD4+ T cells and highly dependent on the induction of endogenous IFN-3. Given (1) our extensive immunological characterization of rCPAF vaccination in conferring protective immunity against genital chlamydial infection in the mouse model, and (2) that the pathogenesis and immunity to chlamydial infection in guinea pigs has been shown to be remarkably similar to chlamydial genital infection in humans, we hypothesize that "vaccination with rCPAF will induce protective immunity against inflammatory pathology induced by genital chlamydial infection in guinea pigs". We propose to translate and validate the protective efficacy of rCPAF in an alternative animal model the guinea pig with C. caviae, the causative agent of guinea pig inclusion conjunctivitis (GPIC). The results obtained from these findings will provide important insights into the design of an effective anti-chlamydial vaccine for human use. This study will enable propogation of the guinea pig model of genital chlamydial infection established by Dr. Roger Rank (letter of support), which has been put to limited use in translational vaccine studies. Moreover, the completion of the sequencing of the guinea pig genome will result in the development of immunological reagents for characterization, which will further facilitate the use of this animal model in the scientific community.
描述(由申请人提供):沙眼衣原体是世界范围内细菌性传播疾病的主要原因。未经治疗的生殖器衣原体感染会引起严重的后遗症,如盆腔炎、异位妊娠和不孕症。获得许可的疫苗被认为是限制衣原体引起的发病率的理想方法,但目前还没有。衣原体蛋白酶样活性因子(CPAF)是一种高度保守的细菌蛋白,分泌到宿主细胞质中。我们的实验室已经证明了鼻内接种重组(r) CPAF(血清型L2)对小鼠生殖器衣原体感染和病理的保护作用。这种保护是由抗原特异性CD4+ T细胞介导的,高度依赖于内源性IFN-3的诱导。考虑到(1)我们对接种rCPAF疫苗在小鼠模型中获得对生殖器衣原体感染的保护性免疫的广泛免疫学特性,以及(2)豚鼠对衣原体感染的发病机制和免疫已被证明与人类对生殖器衣原体感染的免疫非常相似,我们假设“接种rCPAF疫苗将诱导对豚鼠生殖器衣原体感染引起的炎症病理的保护性免疫”。我们建议在豚鼠包涵性结膜炎(GPIC)的病原体caviae豚鼠模型上翻译并验证rCPAF的保护作用。从这些发现中获得的结果将为设计用于人类的有效抗衣原体疫苗提供重要见解。这项研究将使Roger Rank博士(支持信)建立的生殖器衣原体感染豚鼠模型得以传播,该模型已在转译疫苗研究中得到有限的使用。此外,豚鼠基因组测序的完成将导致用于表征的免疫试剂的开发,这将进一步促进该动物模型在科学界的使用。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Chlamydial protease-like activity factor mediated protection against C. trachomatis in guinea pigs.
  • DOI:
    10.1038/icb.2016.122
  • 发表时间:
    2017-05
  • 期刊:
  • 影响因子:
    4
  • 作者:
    Wali S;Gupta R;Yu JJ;Lanka GKK;Chambers JP;Guentzel MN;Zhong G;Murthy AK;Arulanandam BP
  • 通讯作者:
    Arulanandam BP
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Bernard Pragash Arulanandam其他文献

Bernard Pragash Arulanandam的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Bernard Pragash Arulanandam', 18)}}的其他基金

Thioredoxin mediated Acinetobacter baumannii colonization in the GI tract
硫氧还蛋白介导的鲍曼不动杆菌在胃肠道中的定植
  • 批准号:
    9092838
  • 财政年份:
    2016
  • 资助金额:
    $ 7.23万
  • 项目类别:
The Contribution of MicroRNA-182 in Genital Chlamydia trachomatis Infection
MicroRNA-182在生殖器沙眼衣原体感染中的作用
  • 批准号:
    9318447
  • 财政年份:
    2016
  • 资助金额:
    $ 7.23万
  • 项目类别:
Evaluation of CPAF Mediated Anti-Chlamydial Immunity in the Guinea Pig
CPAF 介导的豚鼠抗衣原体免疫的评价
  • 批准号:
    8030633
  • 财政年份:
    2011
  • 资助金额:
    $ 7.23万
  • 项目类别:
CPAF induced CD4+ T cell mediated immunity against Chlamydia
CPAF 诱导 CD4 T 细胞介导的针对衣原体的免疫
  • 批准号:
    8128112
  • 财政年份:
    2010
  • 资助金额:
    $ 7.23万
  • 项目类别:
CPAF induced CD4+ T cell mediated immunity against Chlamydia
CPAF 诱导 CD4 T 细胞介导的针对衣原体的免疫
  • 批准号:
    8197433
  • 财政年份:
    2008
  • 资助金额:
    $ 7.23万
  • 项目类别:
CPAF induced CD4+ T cell mediated immunity against Chlamydia
CPAF 诱导 CD4 T 细胞介导的针对衣原体的免疫
  • 批准号:
    7993092
  • 财政年份:
    2008
  • 资助金额:
    $ 7.23万
  • 项目类别:
CPAF induced CD4+ T cell mediated immunity against Chlamydia
CPAF 诱导 CD4 T 细胞介导的针对衣原体的免疫
  • 批准号:
    7742663
  • 财政年份:
    2008
  • 资助金额:
    $ 7.23万
  • 项目类别:
CPAF induced CD4+ T cell mediated immunity against Chlamydia
CPAF 诱导 CD4 T 细胞介导的针对衣原体的免疫
  • 批准号:
    8389670
  • 财政年份:
    2008
  • 资助金额:
    $ 7.23万
  • 项目类别:
CPAF induced CD4+ T cell mediated immunity against Chlamydia
CPAF 诱导 CD4 T 细胞介导的针对衣原体的免疫
  • 批准号:
    7579715
  • 财政年份:
    2008
  • 资助金额:
    $ 7.23万
  • 项目类别:
Mapping of F. tularensis T cell epitopes in Mice
小鼠 T 细胞表位定位
  • 批准号:
    6912412
  • 财政年份:
    2005
  • 资助金额:
    $ 7.23万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 7.23万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 7.23万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 7.23万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 7.23万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 7.23万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 7.23万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 7.23万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 7.23万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 7.23万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 7.23万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了